These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Large animal models for foamy virus vector gene therapy. Trobridge GD; Horn PA; Beard BC; Kiem HP Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198 [TBL] [Abstract][Full Text] [Related]
23. Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector. Sweeney NP; Regan C; Liu J; Galleu A; Dazzi F; Lindemann D; Rupar CA; McClure MO Mol Ther; 2016 Aug; 24(7):1227-36. PubMed ID: 27133965 [TBL] [Abstract][Full Text] [Related]
24. Ex vivo gene delivery to synovium using foamy viral vectors. Armbruster N; Weber C; Wictorowicz T; Rethwilm A; Scheller C; Steinert AF J Gene Med; 2014; 16(7-8):166-78. PubMed ID: 25044583 [TBL] [Abstract][Full Text] [Related]
25. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential. Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446 [TBL] [Abstract][Full Text] [Related]
26. Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Bougioukli S; Saitta B; Sugiyama O; Tang AH; Elphingstone J; Evseenko D; Lieberman JR Hum Gene Ther; 2019 Jul; 30(7):906-917. PubMed ID: 30773946 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells. Everson EM; Hocum JD; Trobridge GD J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087 [TBL] [Abstract][Full Text] [Related]
28. Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia. McGinley L; McMahon J; Strappe P; Barry F; Murphy M; O'Toole D; O'Brien T Stem Cell Res Ther; 2011 Mar; 2(2):12. PubMed ID: 21385372 [TBL] [Abstract][Full Text] [Related]
29. Lentivector integration sites in ependymal cells from a model of metachromatic leukodystrophy: non-B DNA as a new factor influencing integration. McAllister RG; Liu J; Woods MW; Tom SK; Rupar CA; Barr SD Mol Ther Nucleic Acids; 2014 Aug; 3(8):e187. PubMed ID: 25158091 [TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells as cellular vectors for pediatric neurological disorders. Phinney DG; Isakova IA Brain Res; 2014 Jul; 1573():92-107. PubMed ID: 24858930 [TBL] [Abstract][Full Text] [Related]
31. Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases. Williams DA; Thrasher AJ Stem Cells Transl Med; 2014 May; 3(5):636-42. PubMed ID: 24682287 [TBL] [Abstract][Full Text] [Related]
33. Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities. Lin P; Lin Y; Lennon DP; Correa D; Schluchter M; Caplan AI Stem Cells Transl Med; 2012 Dec; 1(12):886-97. PubMed ID: 23283550 [TBL] [Abstract][Full Text] [Related]
34. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. Lalu MM; McIntyre L; Pugliese C; Fergusson D; Winston BW; Marshall JC; Granton J; Stewart DJ; PLoS One; 2012; 7(10):e47559. PubMed ID: 23133515 [TBL] [Abstract][Full Text] [Related]